CompletedEUCTR 2018-002782-19
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRE...
This historical record does not confirm current site availability.
Historical research recordAges 18–65Multiple countriesDepression
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Phoenix and 124 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: November 9, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 759
- Sponsor
- Allergan Ltd.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, United Kingdom, Bulgaria, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- EUCTR 2018-002782-19
- Official title
Show the full official title
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRE...
Recruitment & locations
CompletedPhoenix, United States · Little Rock, United States · Rogers, United States
97 more locations
- Anaheim, United States
- Colton, United States
- Costa Mesa, United States
- Culver City, United States
- Garden Grove, United States
- Irvine, United States
- La Habra, United States
- Lemon Grove, United States
- Redlands, United States
- San Diego, United States
- Temecula, United States
- Clearwater, United States
- Hallandale, United States
- Hialeah, United States
- Jacksonville, United States
- Palm Bay, United States
- Tampa, United States
- Alpharetta, United States
- Decatur, United States
- Marietta, United States
- Libertyville, United States
- Lincolnwood, United States
- Winfield, United States
- Lake Charles, United States
- Shreveport, United States
- Baltimore, United States
- Gaithersburg, United States
- Ann Arbor, United States
- Bloomfield Hills, United States
- Flowood, United States
- St Louis, United States
- Lincoln, United States
- Las Vegas, United States
- Berlin, United States
- Brooklyn, United States
- New York, United States
- Rochester, United States
- Charlotte, United States
- Raleigh, United States
- Avon Lake, United States
- Cincinnati, United States
- Columbus, United States
- West Chester, United States
- Oklahoma City, United States
- Portland, United States
- Allentown, United States
- North Charleston, United States
- Franklin, United States
- Memphis, United States
- Austin, United States
- Bellaire, United States
- Dallas, United States
- Friendswood, United States
- Houston, United States
- Plano, United States
- Richardson, United States
- Woodstock, United States
- Bellevue, United States
- Everett, United States
- Sofiya, Bulgaria
- Kardzhali, Bulgaria
- Kazanlak, Bulgaria
- Pleven, Bulgaria
- Plovdiv, Bulgaria
- Rousse, Bulgaria
- Sofia, Bulgaria
- Targovishte, Bulgaria
- Varna, Bulgaria
- Veliko Tarnovo, Bulgaria
- Vratsa, Bulgaria
- Tartu, Estonia
- Tallinn, Estonia
- Frankfurt am Main, Germany
- Berlin, Germany
- Chemnitz, Germany
- Westerstede, Germany
- Pécs, Hungary
- Kalocsa, Hungary
- Gyöngyös, Hungary
- Tatabánya, Hungary
- Budapest, Hungary
- Smila, Ukraine
- Kryvbas Village, Ukraine
- Ivano-Frankivsk, Ukraine
- Kharkiv, Ukraine
- Stepanivka Village, Ukraine
- Oleksandrivka Village, Ukraine
- Uzhhorod, Ukraine
- Kyiv, Ukraine
- Lviv, Ukraine
- Odesa, Ukraine
- Ternopil, Ukraine
- Vinnytsia, Ukraine
- Plymouth, United Kingdom
- Chertsey, United Kingdom
- Blackpool, United Kingdom
- Manchester, United Kingdom
Registry details
Original registry record (opens in a new tab)Historical country statuses
- Bulgaria — Completed
- Germany — Completed
- United Kingdom — GB - no longer in EU/EEA
- Hungary — Completed
Questions about this study
Who is behind this study?
The study sponsor is Allergan Ltd.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me